This is an AMP page which is for mobile devices.

View Non AMP page

Twitter

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / PTCT - PTC Therapeutics GAAP EPS of $0.20, revenue of $211M beats by $35.48M

PTCT - PTC Therapeutics GAAP EPS of $0.20, revenue of $211M beats by $35.48M

November, 04 2025 04:25 PM PTC Therapeutics Inc.

2025-11-04 16:25:34 ET

More on PTC Therapeutics

PTC Therapeutics, Inc. (PTCT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
PTC Therapeutics, Inc. (PTCT) Presents At Cantor Global Healthcare Conference 2025 Transcript
PTC Therapeutics, Inc. (PTCT) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript
PTC Therapeutics rare disease therapy rejected by FDA
PTC Therapeutics outlines Sephience $1B-plus U.S. revenue potential following FDA and EU launches

For further details see:

PTC Therapeutics GAAP EPS of $0.20, revenue of $211M beats by $35.48M

Stock Information

Company Name:	PTC Therapeutics Inc.
Stock Symbol:	PTCT
Market:	NASDAQ
Website:	ptcbio.com

Get PTCT Alerts

News, Short Squeeze, Breakout and More Instantly...

Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.